Eugene Durenard - Jan 8, 2022 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)

Role
Director
Signature
/s/ Eugene Durenard
Stock symbol
CODX
Transactions as of
Jan 8, 2022
Transactions value $
$0
Form type
4
Date filed
1/10/2022, 04:05 PM
Previous filing
Sep 22, 2021
Next filing
Jul 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CODX Common Stock Award $0 +12.5K $0.00 12.5K Jan 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CODX Restricted Stock Units Options Exercise $0 -12.5K -50% $0.00 12.5K Jan 8, 2022 Common Stock 25K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021.